Market Research Logo

Drug Discovery Technologies

Drug Discovery Technologies

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

This report provides:

An overview of the global markets for drug discovery technologies.

Analyses of global market trends, with data from 2012-2014, and projections of CAGRs through 2019.

A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches.

Descriptions of various products such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.

Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies accross different segments of the industry.


SCOPE OF THE STUDY

BCC Research conducted an assessment of the market, which includes the global and regional breakdown of sales data, market forecasting, available drug discovery technologies in the market, application of the technologies in commercial and research practice, regulatory aspects, patent analysis, market leaders and market share and so forth for the drug discovery technologies.

The report offers a summary of the global drug discovery technologies market along with region-wise sales analysis of regions such as North America (the U.S. and Canada), Europe and emerging markets (Asian countries, South America, parts of Africa, Russia etc.). The application of drug discovery technologies is based on the commercial and R&D uses of those technologies/products/platforms.

The sales data for the global and regional markets were substantiated for the present and projected values through statistical analysis. The technology details in the report are based on their present/prospective application and expediency.

CHAPTER 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2012-2019 ($ MILLIONS)
CHAPTER 3 OVERVIEW
CLASSIFICATION
HIGH-THROUGHPUT SCREENING (HTS)
BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY
High-performance Liquid Chromatography Equipment and Accessories
Mass Spectrometry Equipment and Accessories
NMR in Drug Discovery
X-ray Crystallography
Microscopy
Light Microscopy
Fluorescence Microscopy
Confocal Microscopy
Electron Microscopy
CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
Cell-based Assays
G Protein-coupled Receptors as Targets
Ion Channel as Target for Cell-based Assay Development
Cell Biology Reagents
TABLE 1 CELL BIOLOGY REAGENTS AND THEIR FUNCTIONS
Stem Cell Research
PROTEOMICS DRUG DISCOVERY
Protein-protein Interaction
Protein Microarrays (Protein Chip Technology)
TABLE 2 PROTEIN MICROARRAY AND THEIR FUNCTIONS
Two-Dimensional Gel Electrophoresis (2DGE)
GENOMICS DRUG DISCOVERY
Polymerase Chain Reaction (PCR)
DNA Microarrays
RNA Interference
Next-generation Sequencing
Epigenetic Drugs
Histone Deacetylases (HDACs)
DNA Methyltransferases (DNMT)
Histone Methyltransferases (MT)
BIOINFORMATICS AS PLATFORM FOR DRUG DISCOVERY
OTHER - METABOLOMICS-BASED TECHNOLOGIES, COMBINATORIAL
CHEMISTRY, SYSTEMS BIOLOGY, NANOTECHNOLOGY
Metabolomics
Combinatorial Chemistry
TABLE 3 DIFFERENCE BETWEEN SOLID-PHASE AND SOLUTION-PHASE
SYNTHESIS
Systems Biology
Nanotechnology
DRUG DISCOVERY PROCESS
FIGURE 1 DRUG DISCOVERY PROCESS
CHAPTER 4 REGULATORY ASPECTS
FIGURE 2 STEPS TO DRUG DISCOVERY UNTIL REGULATORY APPROVAL
DRUG DEVELOPMENT TECHNOLOGIES AND REGULATIONS
HIGH-THROUGHPUT SCREENING
BIOANALYTICAL INSTRUMENTS
CELL-BASED ASSAYS
GENOMICS AND PROTEOMICS
Microarray
BIOINFORMATICS
NANOTECHNOLOGY
REGULATORY DEVELOPMENTS OF DRUG DISCOVERY TECHNOLOGIES
CHAPTER 5 NEW DEVELOPMENTS
TABLE 4 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
TABLE 5 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
TABLE 6 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
TABLE 7 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
TABLE 8 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
TABLE 9 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
CHAPTER 6 MARKET ANALYSIS
MARKET BY TYPE
TABLE 10 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 3 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
HIGH-THROUGHPUT SCREENING
Market Overview
Market Revenue
TABLE 11 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
FIGURE 4 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012-2019 ($ MILLIONS)
BIOANALYTICAL INSTRUMENTS
Market Overview
Market Revenue
TABLE 12 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 5 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, 2012-2019 ($ MILLIONS)
CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 13 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, 2012-2019 ($ MILLIONS)
PROTEOMICS DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 14 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
GENOMICS DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 15 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 8 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
BIOINFORMATICS AS PLATFORM FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 16 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
FIGURE 9 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, 2012-2019 ($ MILLIONS)
OTHER DRUG DISCOVERY TECHNOLOGIES
Market Overview
Market Revenue
TABLE 17 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 10 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 18 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
FIGURE 11 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 19 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 12 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
HIGH-THROUGHPUT SCREENING
Market Overview
Market Revenue
TABLE 20 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 13 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 21 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 14 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
High-performance Liquid Chromatography Equipment and Accessories
TABLE 22 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 15 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, 2012-2019 ($ MILLIONS)
Mass Spectrometry Equipment and Accessories
TABLE 23 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 16 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
Nuclear Magnetic Resonance
TABLE 24 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 17 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
Microscopy
TABLE 25 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 18 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
X-ray Crystallography
TABLE 26 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 19 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 27 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 20 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
Cell-based Assays for Drug Discovery
TABLE 28 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 21 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
Cell Biology Reagents
TABLE 29 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 22 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, 2012-2019 ($ MILLIONS)
PROTEOMICS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 30 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 23 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
Two-dimensional Gel Electrophoresis
TABLE 31 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, THROUGH 2019 ($MILLIONS)
FIGURE 24 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, 2012-2019 ($ MILLIONS)
Protein Microarrays/Protein Chips
TABLE 32 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 25 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
GENOMICS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 33 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 26 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, 2012-2019 ($ MILLIONS)
Polymerase Chain Reaction
TABLE 34 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 27 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, 2012-2019 ($ MILLIONS)
Deoxyribonucleic Acid Microarrays
TABLE 35 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 28 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, 2012-2019 ($ MILLIONS)
Ribonucleic Acid Interference
TABLE 36 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 29 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
Next-Generation Sequencing
TABLE 37 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 30 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
Epigenetics
TABLE 38 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 31 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, 2012- 2019 ($ MILLIONS)
BIOINFORMATICS FOR DRUG DISCOVERY
Market Overview
Market Revenue
TABLE 39 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 32 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
OTHER DRUG DISCOVERY TECHNOLOGIES
Market Overview
Market Revenue
TABLE 40 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 33 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
Metabolomics
TABLE 41 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 34 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
Combinatorial Chemistry
TABLE 42 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 35 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, 2012-2019 ($ MILLIONS)
Systems Biology
TABLE 43 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 36 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, 2012-2019 ($ MILLIONS)
Nanotechnology
TABLE 44 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 37 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 45 TABLE 45 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)
FIGURE 38 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)
CHAPTER 7 INDUSTRY STRUCTURE
HIGH-THROUGHPUT SCREENING
MARKET LEADERS
TABLE 46 LEADING MANUFACTURERS/SUPPLIERS OF HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
MARKET SHARE
TABLE 47 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
FIGURE 39 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
BIOANALYTICAL INSTRUMENTS
MARKET LEADERS
TABLE 48 LEADING MANUFACTURERS/SUPPLIERS OF BIOANALYTICAL INSTRUMENTS, 2013
MARKET SHARE
TABLE 49 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
FIGURE 40 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
CELL-BASED ASSAYS AND REAGENTS
MARKET LEADERS
TABLE 50 LEADING MANUFACTURERS/SUPPLIERS OF CELL-BASED ASSAYS AND REAGENTS, 2013
MARKET SHARE
TABLE 51 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
FIGURE 41 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
PROTEOMICS
MARKET LEADERS
TABLE 52 LEADING MANUFACTURERS/SUPPLIERS OF PROTEOMICS TECHNOLOGY, 2013
MARKET SHARE
TABLE 53 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
FIGURE 42 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
GENOMICS
MARKET LEADERS
TABLE 54 LEADING MANUFACTURERS/SUPPLIERS OF GENOMICS TECHNOLOGY, 2013
MARKET SHARE
TABLE 55 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
FIGURE 43 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
BIOINFORMATICS
MARKET LEADERS
TABLE 56 LEADING MANUFACTURERS/SUPPLIERS OF BIOINFORMATICS TECHNOLOGY, 2013
MARKET SHARE
TABLE 57 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
FIGURE 44 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
OTHER DRUG DISCOVERY TECHNOLOGIES
MARKET LEADERS
TABLE 58 LEADING MANUFACTURERS/SUPPLIERS OF OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
MARKET SHARE
TABLE 59 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)
FIGURE 45 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)
CHAPTER 8 MARKET BY APPLICATION
INDUSTRIAL PHARMACEUTICAL/ BIOPHARMACEUTICAL MANUFACTURING
PHARMACEUTICAL/ BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
GLOBAL DRUG DISCOVERY TECHNOLOGY MARKET BY APPLICATION
TABLE 60 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 46 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 61 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
FIGURE 47 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
HIGH-THROUGHPUT SCREENING
MARKET OVERVIEW
MARKET REVENUE
TABLE 62 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 48 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
BIOANALYTICAL INSTRUMENTS
MARKET OVERVIEW
MARKET REVENUE
TABLE 63 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 49 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
CELL-BASED ASSAYS AND REAGENTS
MARKET OVERVIEW
MARKET REVENUE
TABLE 64 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 50 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
PROTEOMICS TECHNOLOGY
MARKET OVERVIEW
MARKET REVENUE
TABLE 65 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 51 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
GENOMICS TECHNOLOGY
MARKET OVERVIEW
MARKET REVENUE
TABLE 66 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 52 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
BIOINFORMATICS TECHNOLOGY
MARKET OVERVIEW
MARKET REVENUE
TABLE 67 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
FIGURE 53 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
OTHER DRUG DISCOVERY TECHNOLOGIES
MARKET OVERVIEW
MARKET REVENUE
TABLE 68 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($MILLIONS)
FIGURE 54 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)
CHAPTER 9 PATENT ANALYSIS
PATENTS BY YEAR
TABLE 69 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
FIGURE 55 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCT TYPE
TABLE 70 NUMBER OF U.S. PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCTS CATEGORY, 2012 TO JULY 2014 (NUMBER)
PATENTS BY COUNTRY
HIGH-THROUGHPUT SCREENING TECHNOLOGY
TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
TABLE 72 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
FIGURE 56 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
BIOANALYTICAL INSTRUMENTS
TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
TABLE 74 PATENT SHARES BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (%)
CELL-BASED ASSAYS AND REAGENTS
TABLE 75 NUMBER OF U.S. PATENTS BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
TABLE 76 PATENT SHARES BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (%)
PROTEOMICS
TABLE 77 NUMBER OF U.S. PATENTS BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
TABLE 78 PATENT SHARES BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
GENOMICS
TABLE 79 NUMBER OF U.S. PATENTS BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
TABLE 80 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
FIGURE 57 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
BIOINFORMATICS PLATFORM
TABLE 81 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
(NUMBER)
TABLE 82 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
FIGURE 58 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
OTHER DRUG DISCOVERY TECHNOLOGIES
TABLE 83 NUMBER OF U.S. PATENTS BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
TABLE 84 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
FIGURE 59 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012-2014 (JULY) (%)
PATENTS BY COMPANY
HIGH-THROUGHPUT SCREENING TECHNOLOGY
TABLE 85 NUMBER OF U.S. PATENTS BY COMPANY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
BIOANALYTICAL INSTRUMENTS
TABLE 86 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
CELL-BASED ASSAYS AND REAGENTS
TABLE 87 NUMBER OF U.S. PATENTS BY COMPANY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
PROTEOMICS
TABLE 88 NUMBER OF U.S. PATENTS BY COMPANY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
GENOMICS
TABLE 89 NUMBER OF U.S. PATENTS BY COMPANY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
BIOINFORMATICS PLATFORM
TABLE 90 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
OTHER DRUG DISCOVERY TECHNOLOGIES
TABLE 91 NUMBER OF U.S. PATENTS BY COMPANY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
PATENTS BY ASSIGNEE
HIGH-THROUGHPUT SCREENING TECHNOLOGY
TABLE 92 U.S. PATENTS BY ASSIGNEE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
BIOANALYTICAL INSTRUMENTS
TABLE 93 U.S. PATENTS BY ASSIGNEE FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
CELL-BASED ASSAYS AND REAGENTS
TABLE 94 U.S. PATENTS BY ASSIGNEE FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
PROTEOMICS
TABLE 95 U.S. PATENTS BY ASSIGNEE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
GENOMICS
TABLE 96 U.S. PATENTS BY ASSIGNEE FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
BIOINFORMATICS PLATFORM
TABLE 97 U.S. PATENTS BY ASSIGNEE FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
OTHER DRUG DISCOVERY TECHNOLOGIES
TABLE 98 U.S. PATENTS BY ASSIGNEE FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
CHAPTER 10 CURRENT SITUATION
NEW DRUG DISCOVERY TECHNOLOGIES AND PLATFORMS
NANOPARTICLE TRACKING ANALYSIS
AUTOFLUORESCENCE REDUCTION TECHNOLOGY
BIOCEL SYSTEM
BIONUMERICS
GENEVATM GENOMIC MARKERS DISCOVERY PLATFORM
FACTORS AFFECTING THE MARKET FOR DRUG DISCOVERY TECHNOLOGIES
CURRENT DRIVERS FOR THE MARKET OF DRUG DISCOVERY TECHNOLOGIES
COLLABORATIONS/ACQUISITIONS
CHAPTER 11 COMPANY PROFILES
AB SCIEX
ACCELRYS (NOW BIOVIA)
AFFYMETRIX INC.
AGILENT TECHNOLOGIES INC
AMETEK PROCESS INSTRUMENTS
APPLIED MATHS NV
BAYER TECHNOLOGY SERVICES GMBH
BD BIOSCIENCES
BECKMAN COULTER INC.
BIOCRATES LIFE SCIENCES AG
BIOMAX INFORMATICS AG
BIO-RAD LABORATORIES INC.
BIOTECH SUPPORT GROUP
BIOTEK INSTRUMENTS INC.
BRUKER
CEPHEID
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CHENOMX
CISBIO BIOASSAYS
CODEX BIOSOLUTIONS INC.
COMPUGEN LTD.
EMD MILLIPORE
GE HEALTHCARE LIFESCIENCES
GENEVA BIOINFORMATICS SA
GENOMATIX SOFTWARE GMBH
GENOSPLICE TECHNOLOGY
HAMILTON ROBOTICS INC.
HIGHCHEM LTD. SLOVAKIA
HITACHI HIGH-TECHNOLOGIES CORP.
HUMAN METABOLOME TECHNOLOGIES INC.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
IROA TECHNOLOGIES (FORMERLY NEXTGEN METABOLOMICS)
JEOL LTD
LEICA MICROSYSTEMS
LONZA GROUP AG
METABOLON INC.
MOLECULAR DEVICES LLC
MULTISPAN INC.
OPGEN INC.
PERKINELMER INC.
PROMEGA CORP.
QIAGEN NV
ROCHE HOLDING LTD
SHIMADZU
SIDMAP LLC
SIGMA-ALDRICH CORP.
SOMALOGIC INC.
THERMO FISHER SCIENTIFIC INC.
THOMSON REUTERS
WATERS CORP.
ZEISS
CHAPTER 12 APPENDIX-ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report